Adcetris (brentuximab vedotin )

pCPA File Number: 22856
Negotiation Status:
Concluded with an LOI
Indication(s):
Hodgkin's Lymphoma
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
PC0371-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: